Hiroki Kato

8PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersAcceleratorsCancer diagnosisBiomedical imagingGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 09, 2025
Potentially fatal crisis after 177Lu-DOTATATE therapy for paraganglioma: a case report with review of literature.

Aoki Tobimatsu, Kosuke Mukai, Yoshinari Obata

|Dec 23, 2022
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.

Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga

|Sep 03, 2022
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose-positron emission tomography to differentiate between benign and malignant lesions.

Mirei Watanabe, Hiroki Kato, Daisuke Katayama

|Jul 07, 2022
Impaired neuronal integrity in traumatic brain injury detected by 123I-iomazenil single photon emission computed tomography and MRI.

Hiroki Kato, Jyoji Nakagawara, Kenji Hachisuka

|Aug 07, 2021
Evaluation of Integrin αvβ3 Expression in Murine Xenograft Models: [68Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation.

Kosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka

|Jul 29, 2021
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy.

Hiroki Kato, Xuhao Huang, Yuichiro Kadonaga

Pageof 2

Frequent Collaborators

1 joint publications

Hiromasa Kuroda

1 joint publications

Kosuke Mitsuyuki

1 joint publications

Tadashi Watabe

1 joint publications

Xuhao Huang